Search Results - "BERGER, Barry M"

Refine Results
  1. 1
  2. 2

    A Simplified, Noninvasive Stool DNA Test for Colorectal Cancer Detection by ITZKOWITZ, Steven, BRAND, Randall, PASZAT, Lawrence, BERGER, Barry M, JANDORF, Lina, DURKEE, Kris, MILLHOLLAND, John, RABENECK, Linda, SCHROY, Paul C, SONTAG, Stephen, JOHNSON, David, MARKOWITZ, Sanford

    Published in The American journal of gastroenterology (01-11-2008)
    “…As a noninvasive colorectal cancer (CRC) screening test, a multi-marker first generation stool DNA (sDNA V 1.0) test is superior to guaiac-based fecal occult…”
    Get full text
    Journal Article
  3. 3

    Analytical Validation of NavDx, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Cancers by Gunning, Alicia, Kumar, Sunil, Williams, Cassin Kimmel, Berger, Barry M, Naber, Stephen P, Gupta, Piyush B, Del Vecchio Fitz, Catherine, Kuperwasser, Charlotte

    Published in Diagnostics (Basel) (01-02-2023)
    “…The NavDx blood test analyzes tumor tissue modified viral (TTMV)-HPV DNA to provide a reliable means of detecting and monitoring HPV-driven cancers. The test…”
    Get full text
    Journal Article
  4. 4

    Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT) by Heigh, Russell I, Yab, Tracy C, Taylor, William R, Hussain, Fareeda T N, Smyrk, Thomas C, Mahoney, Douglas W, Domanico, Michael J, Berger, Barry M, Lidgard, Graham P, Ahlquist, David A

    Published in PloS one (20-01-2014)
    “…Precursors to 1/3 of colorectal cancer (CRC), serrated polyps have been under-detected by screening due to their inconspicuous, non-hemorrhagic, and proximal…”
    Get full text
    Journal Article
  5. 5

    Novel Coagulation Test Detects Anticoagulation Resistance and Is Associated With Thrombotic Events in Pediatric Patients Requiring Extracorporeal Membrane Oxygenation by Frydman, Galit H, Berger, Barry M, Kostousov, Vadim, Bruzdovski, Karen, Papageorgiou, Dimitrios P, Navaei, Amir, Hui, Shiu-Ki Rocky, Teruya, Jun

    Published in Critical care explorations (01-10-2022)
    “…Bivalirudin, an IV direct thrombin inhibitor, and unfractionated heparin (UFH) are frequently used anticoagulants in the pediatric critical care setting. An…”
    Get full text
    Journal Article
  6. 6

    Multitarget stool DNA for colorectal cancer screening:A review and commentary on the United States Preventive Services Draft Guidelines by Berger, Barry M, Levin, Bernard, Hilsden, Robert J

    Published in World journal of gastrointestinal oncology (15-05-2016)
    “…Multitarget stool DNA(mt-sDNA) testing was approved for average risk colorectal cancer(CRC) screening by the United States Food and Drug Administration and…”
    Get full text
    Journal Article
  7. 7

    Multitarget Stool DNA Testing for Colorectal-Cancer Screening by Imperiale, Thomas F, Ransohoff, David F, Itzkowitz, Steven H, Levin, Theodore R, Lavin, Philip, Lidgard, Graham P, Ahlquist, David A, Berger, Barry M

    Published in The New England journal of medicine (03-04-2014)
    “…A stool test that measures mutant KRAS, abnormal gene methylation, and hemoglobin detected significantly more colorectal cancers than a commercial fecal…”
    Get full text
    Journal Article
  8. 8

    Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma by Berger, Barry M, Hanna, Glenn J, Posner, Marshall R, Genden, Eric M, Lautersztain, Julio, Naber, Stephen P, Del Vecchio Fitz, Catherine, Kuperwasser, Charlotte

    Published in Clinical cancer research (03-10-2022)
    “…Despite generally favorable outcomes, 15% to 25% of patients with human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma (OPSCC) will have…”
    Get full text
    Journal Article
  9. 9

    Specificity of the Multi-Target Stool DNA Test for Colorectal Cancer Screening in Average-Risk 45-49 Year-Olds: A Cross-Sectional Study by Imperiale, Thomas F, Kisiel, John B, Itzkowitz, Steven H, Scheu, Bradley, Duimstra, Emma Kate, Statz, Sandra, Berger, Barry M, Limburg, Paul J

    “…High-specificity colorectal cancer screening is desirable to triage patients <50 years for colonoscopy; however, most endorsed colorectal cancer screening…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Performance of multitarget stool DNA testing in African American patients by Cooper, Gregory S., Markowitz, Sanford D., Chen, Zhengyi, Tuck, Missy, Willis, Joseph E., Berger, Barry M., Brenner, Dean E., Li, Li

    Published in Cancer (01-10-2018)
    “…BACKGROUND Multitarget stool DNA (mt‐sDNA) is an approved method for colon cancer screening that is especially relevant for patients who cannot undergo…”
    Get full text
    Journal Article
  12. 12

    The Stool DNA Test Is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia by Ahlquist, David A, Taylor, William R, Mahoney, Douglas W, Zou, Hongzhi, Domanico, Michael, Thibodeau, Stephen N, Boardman, Lisa A, Berger, Barry M, Lidgard, Graham P

    Published in Clinical gastroenterology and hepatology (01-03-2012)
    “…Background & Aims Several noninvasive tests have been developed for colorectal cancer (CRC) screening. We compared the sensitivities of a multimarker test for…”
    Get full text
    Journal Article
  13. 13

    Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates by Berger, Barry M., Ahlquist, David A.

    Published in Pathology (01-02-2012)
    “…Colorectal cancer (CRC), the second most common cause of cancer-related mortality worldwide, is preventable with effective screening and removal of precursor…”
    Get full text
    Journal Article
  14. 14

    Low Incidence of Aerodigestive Cancers in Patients With Negative Results From Colonoscopies, Regardless of Findings From Multitarget Stool DNA Tests by Berger, Barry M, Kisiel, John B, Imperiale, Thomas F, Geenen, Daniel J, Heigh, Russell I, Mahoney, Douglas W, Hilsden, Robert J

    Published in Clinical gastroenterology and hepatology (01-04-2020)
    “…Background & AimsWe aimed to compare the incidence of aerodigestive cancers in persons with negative results from colonoscopies and positive vs negative…”
    Get full text
    Journal Article
  15. 15

    Evaluation of Patients with an Apparent False Positive Stool DNA Test: The Role of Repeat Stool DNA Testing by Cooper, Gregory S., Markowitz, Sanford D., Chen, Zhengyi, Tuck, Missy, Willis, Joseph E., Berger, Barry M., Brenner, Dean E., Li, Li

    Published in Digestive diseases and sciences (01-06-2018)
    “…Background There is uncertainty as to the appropriate follow-up of patients who test positive on multimarker stool DNA (sDNA) testing and have a colonoscopy…”
    Get full text
    Journal Article
  16. 16

    Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests: Data From the New Hampshire Colonoscopy Registry by Anderson, Joseph C., Robinson, Christina M., Hisey, William M., Edwards, David K., Kneedler, Bonny L., Berger, Barry M., Butterly, Lynn F.

    Published in Journal of clinical gastroenterology (01-05-2022)
    “…The US Preventive Services Task Force (USPSTF) includes multitarget stool DNA (mt-sDNA) testing as a colorectal cancer (CRC) screening option in average-risk…”
    Get full text
    Journal Article
  17. 17

    Association of Large Serrated Polyps With Synchronous Advanced Colorectal Neoplasia by DAN LI, CHENGSHI JIN, MCCULLOCH, Charles, KAKAR, Sanjay, BERGER, Barry M, IMPERIALE, Thomas F, TERDIMAN, Jonathan P

    Published in The American journal of gastroenterology (01-03-2009)
    “…Serrated polyps of the colorectum are a histologically and genetically heterogeneous group of lesions, which include classic hyperplasic polyps, sessile…”
    Get full text
    Journal Article
  18. 18

    USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing by Berger, Barry M, Parton, Marcus A, Levin, Bernard

    Published in The American journal of managed care (01-02-2016)
    “…The US Preventive Services Task Force (USPSTF) released draft recommendations regarding colorectal cancer (CRC) screening in October 2015. Despite evidence…”
    Get full text
    Journal Article
  19. 19
  20. 20